Results 251 to 260 of about 445,727 (296)

Acute and chronic impact of interleukin-33 stimulation on chemokines and growth factors in human cord blood-derived mast cells. [PDF]

PLoS One
Bakhashab S, Banafea GH, Ahmed F, Alsolami R, Schulten HJ, Gauthaman K, Naseer MI, Pushparaj PN.   +7 more
europepmc   +1 more source

Interleukin-33 links asthma to alopecia areata: Mendelian randomization and mediation analysis.

Skin Res Technol
Wu P, Tian K, Gao S, Jia Z, Xu W, Wang X, Wu L.   +6 more
europepmc   +1 more source

The Interleukin 33-T Helper 2 Cell Axis Promotes Human Liver Fibrosis. [PDF]

Cell Mol Gastroenterol Hepatol
Lurje I, Tacke F.
europepmc   +1 more source

Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease. [PDF]

Kidney Int Rep
Hofherr A, Liarte Marin E, Musial B, Seth A, Slidel T, Conway J, Baker D, Hansen PBL, Challis B, Bartesaghi S, Bhat M, Pecoits-Filho R, Tu X, Selvarajah V, Woollard K, Heerspink HJL.   +15 more
europepmc   +1 more source

Low Secretory Leukocyte Protease Inhibitor (SLPI)-Level Potentiates Alternaria Extract-Induced T-Helper 2 (Th2) Airway Inflammation via the Interleukin-33 (IL-33) Pathway. [PDF]

Cureus
Hirano T, Koarai A, Ohkouchi S, Sugiura H, Kurosawa H.   +4 more
europepmc   +1 more source

Interleukin-33 promotes intrauterine adhesion formation in mice through the mitogen-activated protein kinase signaling pathway. [PDF]

Commun Biol
Liu D, Yuan L, Xu F, Ma Y, Zhang H, Jin Y, Chen M, Zhang Z, Luo S.   +8 more
europepmc   +1 more source

Circulating interleukin-33 levels in obesity and type 2 diabetes: a systematic review and meta-analysis.

Am J Physiol Endocrinol Metab
Missous G, Van Panhuys N.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Interleukin-33 in health and disease

Nature Reviews Immunology, 2016
Interleukin-33 (IL-33) - a member of the IL-1 family - was originally described as an inducer of type 2 immune responses, activating T helper 2 (TH2) cells and mast cells. Now, evidence is accumulating that IL-33 also potently stimulates group 2 innate lymphoid cells (ILC2s), regulatory T (Treg) cells, TH1 cells, CD8+ T cells and natural killer (NK ...
Foo Yew, Liew, Jean-Philippe, Girard, Heth Roderick, Turnquist   +2 more
openaire   +2 more sources

Interleukin-33: increasing role in dermatological conditions

Archives of Dermatological Research, 2016
Interleukin-33 is a novel and an unconventional member of IL-1 family. It is an inflammation-induced factor with dual function exercising its role as an intracellular regulator of gene expression, as well as, an extracellular alarm mediator. It is a ligand for ST2, a heterodimeric membrane-bound receptor of the orphan IL-1 family receptor.
Balato, Anna, Raimondo, Annunziata, Balato, Nicola, Ayala, Fabio, LEMBO, Serena   +4 more
openaire   +5 more sources

Interleukin-33 in atopic dermatitis

Journal of Dermatological Science, 2019
Atopic dermatitis (AD) is characterized by pruritus, barrier disruption, and inflammationincluding type 2 cytokine production. Interleukin-33 (IL-33) is an inflammatory cytokine that is over-expressed in the keratinocytes of patients with AD. IL-33 transgenic mice, which express IL-33 specifically in keratinocytes, spontaneously develop AD-like eczema,
openaire   +2 more sources